Cargando…
Clinical Characteristics and Treatment for Dupilumab-Related Ocular Complications in Atopic Dermatitis Patients
PURPOSE: Ocular adverse events have been reported in association with dupilumab, a monoclonal antibody to treat allergic diseases including atopic dermatitis (AD). We describe clinical findings and treatment of dupilumab-related ocular complications. PATIENTS AND METHODS: Retrospective study of 19 d...
Autores principales: | Tauqeer, Zujaja, Jinno, Stephanie E, Chung, Caroline W, Massaro-Giordano, Mina, Bunya, Vatinee Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976488/ https://www.ncbi.nlm.nih.gov/pubmed/35378901 http://dx.doi.org/10.2147/OPTH.S336978 |
Ejemplares similares
-
Encounters and medication use for ocular surface disorders among patients treated with dupilumab: A cohort study
por: Barbieri, John S., et al.
Publicado: (2021) -
Dupilumab for atopic dermatitis
Publicado: (2019) -
Effect of Autologous Platelet-Rich Plasma Drops in the Treatment of Ocular Surface Disease
por: Nadelmann, Jennifer B, et al.
Publicado: (2022) -
Ocular Surface Diseases Induced by Dupilumab in Severe Atopic Dermatitis
por: Maudinet, Adrien, et al.
Publicado: (2019) -
Severe atopic dermatitis and dupilumab
por: Bernardo, Wanderley, et al.
Publicado: (2023)